Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (TRAP)
Phase 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ADIPemCis) (TRAP Study)
Sponsor: Polaris Group
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Polaris Group
- Advanced Gastrointestinal (GI) Malignancies · Phase PHASE1/PHASE2 · Feb 2020
- Advanced Solid Cancers · Phase PHASE1 · Feb 2020
- Acute Myeloid Leukemia · Phase PHASE1 · Jul 2019
More terminations from Polaris Group
A PHASE1 clinical study on Glioma and Hepatocellular Carcinoma, this trial is terminated or withdrawn. The trial is conducted by Polaris Group and has accumulated 10 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE1
-
Apr 2020 — Oct 2020 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
▶ Show 5 earlier versions
-
Apr 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Mar 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Polaris Group
For direct contact, visit the study record on ClinicalTrials.gov .